Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.
Prostate Cancer
PROSTATE CANCER ADVISOR
FEATURED CONTENT
-
-
Prostate MRI Improves Confirmatory Biopsy Sensitivity
MRI-guided confirmatory prostate biopsies more accurately detects grade progression among men on active surveillance for prostate cancer compared with TRUS-guided systematic biopsies alone. -
Salvage Radiotherapy Called a Viable Option for Recurrent Prostate Cancer
The authors of new review say the results of the JCOG0401 trial suggest that standard hormonal therapy alone vs salvage radiotherapy is not an appropriate management strategy for recurrence after radical prostatectomy. -
“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19
Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection. -
Federal Ruling Puts Pressure on Clinical Trial Sponsors to Post Data
A federal ruling will force trial sponsors to post basic results on ClinicalTrials.gov, but it is unclear whether this is a feasible mandate.
Current Research Into Pain Assessment
Immunotherapy for Prostate Cancer
Targeted Agents
Targeted Agents (cont.)
Radium-223
Chemotherapy
Immunotherapy
Treatment Sequencing
Androgen Deprivation Therapy
Duration of ADT
Docetaxel in Combination With ADT
HSD3B1 Allele Inheritance Linked With ADT Resistance
ADT and Radiation
Predictions for the Future
PROSTATE CANCER NEWS
10-Year Outcomes Similar for H-IMRT, C-IMRT in Prostate Cancer
Exploring the DNA Methylome in mCRPC Through NGS of Plasma DNA Specimens
Combining MRI-Targeted, Systematic Biopsy Appears Best for PCa Detection
New Study Supports PSA-Stratified Prostate Cancer Screening
Canned, Cooked Tomatoes May Cut Prostate Cancer Risk
Want to read more?
Please login or register first to view this content.
Next post in Prostate Cancer
